Kevin Muir

Insider Reports History

Location
New York, NY
Signature
/s/ Kevin Muir
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Muir:

Company Role Class Num Shares Value Price $ Report Date Ownership
DELCATH SYSTEMS, INC. GM INTERVENTIONAL ONCOLOGY Common Stock 18,582 $69,125 $3.72 19 Mar 2024 Direct
DELCATH SYSTEMS, INC. GM INTERVENTIONAL ONCOLOGY Stock Option (Right to Buy) 113,000 07 Feb 2025 Direct

Insider Reports Filed by Kevin Muir

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DCTH DELCATH SYSTEMS, INC. 07 Feb 2025 1 $0 4 GM INTERVENTIONAL ONCOLOGY 07 Feb 2025, 19:14
DCTH DELCATH SYSTEMS, INC. 19 Mar 2024 1 +$50,001 4 GM INTERVENTIONAL ONCOLOGY 19 Mar 2024, 16:58
DCTH DELCATH SYSTEMS, INC. 12 Feb 2024 1 $0 4 VP COMMERCIAL OPERATIONS 14 Feb 2024, 16:44
DCTH DELCATH SYSTEMS, INC. 12 Jun 2023 1 $0 4 Vice President Commercial Operations 22 Jun 2023, 16:14
DCTH DELCATH SYSTEMS, INC. 08 Feb 2023 1 $0 4 VP COMMERCIAL OPERATIONS 26 Jan 2024, 16:25
DCTH DELCATH SYSTEMS, INC. 04 May 2022 0 $0 3 Vice President Commercial Operations Exhibit List: Exhibit 24 - Power of Attorney 16 May 2022, 19:38